Morin D, Zini R, Brunner F, Sebille B, Tillement J P
J Recept Res. 1983;3(6):773-90. doi: 10.3109/10799898309041959.
(+/-)125 I-cyanopindolol ((+/-) I CYP) was used to characterize beta-adrenoceptors on rat lung and cerebral cortex membranes. The affinity of (+/-) ICYP was higher for lung (Kd = 64.3 pM) at 37 degrees C. The association reaction of (+/-) ICYP was faster with lung (k+1 = 1.52 X 10(9) M-1.min-1) than with cerebral cortex beta-adrenoceptors (k+1 = 1.75 X 10(8) M-1.min-1). In both tissues, the dissociation reaction followed a biphasic process with a fast (t 1/2 = 15.4 min and 5.6 min for lung and cerebral cortex respectively) and a slow component (t 1/2 = 474 min and 255 min for lung and cerebral cortex respectively). The thermodynamic parameters for (+/-) ICYP - beta-adrenoceptors binding have been determined from kinetics and equilibrium studies, for the two tissues, at several temperatures between 0 degrees and 44 degrees C. For lung and cerebral cortex, Arrhenius plots were linear with different energies of activation. Van't Hoff plot was not linear for lung and the standard enthalpy and entropy changes of (+/-) ICYP - beta-adrenoceptors interaction decreased linearly with temperature: the binding occurred with a negative heat capacity change (delta Cp degrees = -368.9 cal. moles-1.K-1) at 25 degrees C. Thermodynamic and kinetic results show that binding of (+/-) ICYP to lung beta-adrenoceptors could involve two successive equilibria with a conformational change of the beta-adrenergic receptor.
(±)-125I-氰基吲哚洛尔((±)I CYP)用于表征大鼠肺和大脑皮质膜上的β-肾上腺素能受体。在37℃时,(±)I CYP对肺的亲和力更高(解离常数Kd = 64.3 pM)。(±)I CYP与肺的结合反应(正向速率常数k +1 = 1.52×10⁹ M⁻¹·min⁻¹)比与大脑皮质β-肾上腺素能受体的结合反应(k +1 = 1.75×10⁸ M⁻¹·min⁻¹)更快。在两种组织中,解离反应均呈现双相过程,具有快速成分(肺和大脑皮质的半衰期t 1/2分别为15.4分钟和5.6分钟)和缓慢成分(肺和大脑皮质的半衰期t 1/2分别为474分钟和255分钟)。通过在0℃至44℃之间的几个温度下对两种组织进行动力学和平衡研究,确定了(±)I CYP与β-肾上腺素能受体结合的热力学参数。对于肺和大脑皮质,阿累尼乌斯图呈线性,具有不同的活化能。肺的范特霍夫图不是线性的,(±)I CYP与β-肾上腺素能受体相互作用的标准焓变和熵变随温度线性降低:在25℃时,结合发生时热容量变化为负(ΔCp° = -368.9 cal·moles⁻¹·K⁻¹)。热力学和动力学结果表明,(±)I CYP与肺β-肾上腺素能受体的结合可能涉及两个连续的平衡过程以及β-肾上腺素能受体的构象变化。